TY - JOUR
T1 - A Regional and Projection-Specific Role of RGSz1 in the Ventrolateral Periaqueductal Grey in the Modulation of Morphine Reward
AU - Sakloth, Farhana
AU - Sanchez-Reyes, Omar B.
AU - Ruiz, Anne
AU - Nicolais, Andrew
AU - Serafini, Randal A.
AU - Pryce, Kerri D.
AU - Bertherat, Feodora
AU - Torres-Berrío, Angélica
AU - Gomes, Ivone
AU - Devi, Lakshmi A.
AU - Wacker, Daniel
AU - Zachariou, Venetia
N1 - Publisher Copyright:
© 2022 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Opioid analgesics exert their therapeutic and adverse effects by activating l opioid receptors (MOPR); however, functional responses to MOPR activation are modulated by distinct signal transduction complexes within the brain. The ventrolateral periaqueductal gray (vlPAG) plays a critical role in modulation of nociception and analgesia, but the exact intracellular pathways associated with opioid responses in this region are not fully understood. We previously showed that knockout of the signal transduction modulator Regulator of G protein Signaling z1 (RGSz1) enhanced analgesic responses to opioids, whereas it decreased the rewarding efficacy of morphine. Here, we applied viral mediated gene transfer methodology and delivered adeno-associated virus (AAV) expressing Cre recombinase to the vlPAG of RGSz1fl\fl mice to demonstrate that downregulation of RGSz1 in this region decreases sensitivity to morphine in the place preference paradigm, under pain-free as well as neuropathic pain states. We also used retrograde viral vectors along with flippase-dependent Cre vectors to conditionally downregulate RGSz1 in vlPAG projections to the ventral tegmental area (VTA) and show that downregulation of RGSz1 prevents the development of place conditioning to low morphine doses. Consistent with the role for RGSz1 as a negative modulator of MOPR activity, RGSz1KO enhances opioid-induced cAMP inhibition in periaqueductal gray (PAG) membranes. Furthermore, using a new generation of bioluminescence resonance energy transfer (BRET) sensors, we demonstrate that RGSz1 modulates Gaz but not other Gai family subunits and selectively impedes MOPR-mediated Gaz signaling events invoked by morphine and other opioids. Our work highlights a regional and circuit- specific role of the G protein-signaling modulator RGSz1 in morphine reward, providing insights on midbrain intracellular pathways that control addiction-related behaviors.
AB - Opioid analgesics exert their therapeutic and adverse effects by activating l opioid receptors (MOPR); however, functional responses to MOPR activation are modulated by distinct signal transduction complexes within the brain. The ventrolateral periaqueductal gray (vlPAG) plays a critical role in modulation of nociception and analgesia, but the exact intracellular pathways associated with opioid responses in this region are not fully understood. We previously showed that knockout of the signal transduction modulator Regulator of G protein Signaling z1 (RGSz1) enhanced analgesic responses to opioids, whereas it decreased the rewarding efficacy of morphine. Here, we applied viral mediated gene transfer methodology and delivered adeno-associated virus (AAV) expressing Cre recombinase to the vlPAG of RGSz1fl\fl mice to demonstrate that downregulation of RGSz1 in this region decreases sensitivity to morphine in the place preference paradigm, under pain-free as well as neuropathic pain states. We also used retrograde viral vectors along with flippase-dependent Cre vectors to conditionally downregulate RGSz1 in vlPAG projections to the ventral tegmental area (VTA) and show that downregulation of RGSz1 prevents the development of place conditioning to low morphine doses. Consistent with the role for RGSz1 as a negative modulator of MOPR activity, RGSz1KO enhances opioid-induced cAMP inhibition in periaqueductal gray (PAG) membranes. Furthermore, using a new generation of bioluminescence resonance energy transfer (BRET) sensors, we demonstrate that RGSz1 modulates Gaz but not other Gai family subunits and selectively impedes MOPR-mediated Gaz signaling events invoked by morphine and other opioids. Our work highlights a regional and circuit- specific role of the G protein-signaling modulator RGSz1 in morphine reward, providing insights on midbrain intracellular pathways that control addiction-related behaviors.
UR - http://www.scopus.com/inward/record.url?scp=85145022704&partnerID=8YFLogxK
U2 - 10.1124/molpharm.122.000528
DO - 10.1124/molpharm.122.000528
M3 - Article
C2 - 36310031
AN - SCOPUS:85145022704
SN - 0026-895X
VL - 103
SP - 1
EP - 8
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 1
ER -